Lichen sclerosus affects an estimated 1 in 300 to 1 in 1,000 people in the general population, making it relatively rare but far from unheard of. The true number is likely higher, because the condition is frequently misdiagnosed or goes undetected for years.
Prevalence by Age and Sex
Lichen sclerosus overwhelmingly affects women, particularly after menopause. A study of female Medicare beneficiaries found a prevalence of 0.7% in postmenopausal women, which translates to roughly 1 in 140. The condition has two peak windows of onset in females: the years before puberty and the perimenopausal or postmenopausal period. Between 7% and 15% of all cases occur in children.
Men develop lichen sclerosus too, though it’s diagnosed less often. In men, the condition almost always involves the foreskin and head of the penis and was historically called balanitis xerotica obliterans. Studies of men undergoing circumcision have found surprisingly high rates of lichen sclerosus in the removed tissue, ranging from 1% to over 60% depending on the population studied. The median age at diagnosis for men in one large study was 65. In mixed groups of adult and pediatric males referred for circumcision, the prevalence was 12% to 14%.
Why the Numbers Are Probably Too Low
Official prevalence figures almost certainly undercount lichen sclerosus. The condition is misdiagnosed at striking rates. In one patient-centered study, over 90% of people who experienced a delayed diagnosis reported being misdiagnosed first. The most common wrong diagnosis was a yeast infection, accounting for nearly 45% of initial misdiagnoses. Others were told they had a sexually transmitted infection, dermatitis, vaginal atrophy, or vulvodynia.
The average delay from first symptoms to a correct diagnosis is roughly three to five years. Adults wait an average of 4.6 years, while a study of prepubertal girls found an average delay of three years, which researchers noted was significantly longer than the one to two years previously assumed. During that time, patients often bounce between multiple specialists, including dermatologists, gynecologists, endocrinologists, gastroenterologists, allergists, and even psychiatrists before finally reaching a provider who recognizes the condition. About 12% of cases are discovered incidentally during a routine exam, meaning the patient had no idea anything was wrong.
Because lichen sclerosus can be asymptomatic, mild, or mistaken for something else, many people with the condition are never formally diagnosed. That gap between reported prevalence and actual prevalence is why experts describe the exact numbers as unknown.
Where It Appears on the Body
In about 85% of cases, lichen sclerosus involves the genital skin. The remaining 15% to 20% of patients develop patches on other parts of the body, including the neck, shoulders, upper back, under the breasts, inner thighs, and wrists. Extragenital involvement can range from a small, well-defined patch to widespread areas of affected skin. Some people have both genital and extragenital lesions at the same time.
Autoimmune Connections
Lichen sclerosus clusters with other autoimmune conditions, which hints at shared underlying immune dysfunction. Between 20% and 30% of women with lichen sclerosus also have another autoimmune disease. Thyroid disorders are the most common overlap, present in 12% to 16% of affected women. Alopecia areata, an autoimmune cause of hair loss, is another recognized association. This pattern suggests that if you already have one autoimmune condition, you may face a modestly higher chance of developing lichen sclerosus.
Cancer Risk in Context
One of the reasons lichen sclerosus gets attention despite its relative rarity is the link to cancer. About 4% of women with the condition eventually develop vulvar squamous cell carcinoma, according to the American Cancer Society. In men, up to 20% with genital lichen sclerosus develop urethral strictures (scar tissue narrowing the urine channel), and a small percentage develop penile cancer. Among men diagnosed with penile squamous cell carcinoma, lichen sclerosus is found in the tissue 28% to 44% of the time.
These numbers don’t mean cancer is likely for any individual patient. A 4% lifetime risk in women means 96 out of 100 will not develop vulvar cancer from the condition. But the elevated risk compared to the general population is why long-term monitoring matters, especially for people with persistent or poorly controlled symptoms.
What Symptoms Look Like
The hallmark signs include porcelain-white patches of skin, intense itching, skin splitting or fissuring, and pain during sex or urination. Over time, untreated lichen sclerosus can cause scarring that changes the structure of genital tissue. In women, this can mean fusion of the labia or narrowing of the vaginal opening. In men, the foreskin can tighten to the point where it can no longer retract.
Some people experience only mild itching or no symptoms at all. Others deal with significant pain that affects daily activities and sexual function. Women whose primary symptom was pain during sex were nearly 10 times more likely to be misdiagnosed compared to those presenting with other symptoms, which partly explains why the diagnostic delay is so long for many patients.